Related Experiment Video
Updated: Jul 1, 2025

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.4K
Phenotypic plasticity - Implications for tumours in bone.
Yujiao Han1, Yibin Kang1,2,3
1Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
Journal of Bone Oncology
|March 7, 2024
Summary
Cancer cells gain adaptability, known as phenotypic plasticity, to spread to new organs. The bone marrow microenvironment fuels this adaptability, impacting cancer treatment effectiveness and enabling tumor growth.
Area of Science:
- Oncology
- Cell Biology
- Cancer Metastasis Research
Background:
- Metastasis significantly contributes to cancer patient mortality.
- Tumor cells exhibit phenotypic plasticity, enabling adaptation to diverse target organs.
- Bone metastasis research offers insights into cancer spread and growth within bone.
Purpose of the Study:
- To review how the bone marrow microenvironment influences metastatic tumor cell plasticity.
- To summarize the impact of plasticity on therapeutic responses.
- To highlight key cellular transformations and adaptations in bone metastasis.
Main Methods:
- Literature review focusing on bone metastasis.
- Analysis of cellular plasticity mechanisms.
- Examination of the bone marrow microenvironment's role.
Main Results:
- The bone marrow microenvironment promotes tumor cell phenotypic plasticity.
- Plasticity alters cancer cells' response to therapies.
- Key transformations include mesenchymal-epithelial transition, stem-like trait acquisition, and dormancy awakening.
- Host-organ mimicry and metabolic rewiring facilitate colonization and growth.
Conclusions:
- Phenotypic plasticity is crucial for cancer cell survival and colonization in bone.
- Understanding these mechanisms can inform new therapeutic strategies for bone metastasis.
More Related Videos
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K

